About Intelligent Therapeutics
Intelligent Therapeutics is a private company based in Eugene, Oregon, incorporated in 2025 in Delaware. It has reported $100,000 raised in one offering on Form D since May 2026. Its chief executive is Jason Gallic.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 13, 2026 | May 28, 2026 | $100,000of $700K target | 2 | $50,000 | Equity, Options, Securities on exercise, Simple Agreement for Future Equity (SAFE)Rule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Intelligent Therapeutics's Form D filed May 28, 2026.
NB
Nathan Bernstein
Chief Technology Officer and director
JG
DS
David Shear
Director
TE
Thomas Emmons
Chief Financial Officer, Secretary and director
MZ
Michael Zvolensky
Chief Science Officer and director